The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial-Reference-Cited by-同舟云学术

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial

Published:2020-02-07 Issue:2 Volume:17 Page:e1003033
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Fredsøe Jacob^ORCID,Koetsenruyter Jan^ORCID,Vedsted Peter,Kirkegaard Pia^ORCID,Væth Michael,Edwards Adrian^ORCID,Ørntoft Torben F.,Sørensen Karina D.^ORCID,Bro Flemming^ORCID

Funder

Strategiske Forskningsråd

Sector skills council for quality and postgraduate training

Kræftens Bekæmpelse

Velux Fonden

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference37 articles.

1. Prostate cancer;JE Damber;Lancet,2008

2. Global cancer statistics, 2002;DM Parkin;CA Cancer J Clin,2005

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;FH Schroder;Lancet,2014

4. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement;Force USPST;Ann Intern Med,2012

5. Risk-based prostate cancer screening;X Zhu;Eur Urol,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review;Journal of Personalized Medicine;2024-08-14

2. The acceptability and clinical impact of using polygenic scores for risk-estimation of common cancers in primary care: a systematic review;Journal of Community Genetics;2024-05-21

3. Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP;BMJ Open;2023-11

4. Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population;European Urology Oncology;2023-10

5. The Role of Pentraxin-3, Fetuin-A and Sirtuin-7 in the Diagnosis of Prostate Cancer;UROL J;2022